Prevacid

Takeda Pharmaceuticals America, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 11, 2023
Approval ID: 71ba78cb-7e46-43eb-9425-fa130f537f84
Products: 3 registered
Version: 44

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PREVACID and PREVACID SOLUTAB safely and effectively. See full prescribing information for PREVACID and PREVACID SOLUTAB. PREVACID (lansoprazole) delayed-release capsules, for oral use PREVACID SOLUTAB (lansoprazole) delayed-release orally disintegrating tablets Initial U.S. Approval: 1995

Quick Stats

Total Products3

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.